Skip to the page

Data / Form D filings / Atommap Corp

Atommap Corp: Form D filings

Atommap Corp, a biotechnology company in New York, NY, filed 2 Form D notices with the SEC between 2023 and 2026. The latest, on March 20, 2026, reports $31.1 million sold of a $59.6 million offering to 29 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1059 3RD AVENUE APARTMENT 17B, New York, NY, 10065
Phone
(917) 968-8176
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2001012

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 20, 2026New notice$59,630,328$31,130,335$28,499,99329Mar 6, 2026sec.gov
Nov 16, 2023New notice$7,084,989$7,084,98931Nov 13, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Huafeng XuExecutive Officer, Director
Keith LoebnerDirector

Other biotechnology companies in New York that filed recently

Every Form D from the week of Mar 16, 2026 · All recent filings in New York · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Atommap Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.